Remove BioTech Remove Health Policy Remove Study
article thumbnail

Income Inequality is Fostering Mis-Trust, the Edelman 2020 Trust Barometer Observes

Health Populi

Together, these three factors erode workers’ confidence in jobs and their personal household economies and financial health. The second chart comes from the study, quantifying global citizens’ trust levels by industry sector since 2012.

BioTech 272
article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.

BioTech 270
article thumbnail

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

Note that hospitals garnered only about one-half of people in this study, and pharma and health plans fell to one-third of Americans’ responses to the question. health care. Now check out the third chart, which is a summary of the Edelman Trust Barometer for 2019 noting Americans’ trust in various industries.

BioTech 166
article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech 166
article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

IQVIA’s national prescription data revealed that prescriptions for mental health drugs grew 8% since 2019 — with a 33% rise among girls under 19. There is another data point in the study on women’s health and prescriptions — for ADHD drugs.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

84% of Americans told the Foundation that they were concerned about how much health care costs will affect them in the future, with 42% of patients saying they couldn’t afford to pay over $500 for an unexpected medical bill. Hospital costs contribute to rising medical costs to 49% of health consumers. Exacerbating U.S.